LivingGLP1
Study S003390

A Real World Study of Lecanemab Treatment in Participants with Early Onset Familial Alzheimer's Disease

Registration

Registration
NCT06883019
Study type
OBSERVATIONAL
Status
RECRUITING
Enrollment
114
Start
2025-03-13
Primary completion
2027-06-30
Lead sponsor
RenJi Hospital
Conditions
Alzheimer Disease
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Chang of CDR-SB score [baseline, 9 month, 18 month]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.